27th Oct 2015 14:09
For immediate release | 27 October 2015 |
ABCAM PLC
("Abcam" or "the Company")
Director Shareholding: Deferred Share Award
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that following approval by the Remuneration Committee, Deferred Share Awards in the form of Nil Cost Options or Conditional Shares ("Award") have today been granted to the following Directors under the Abcam plc Annual Bonus Plan ("Plan") in respect of the financial year ended 30 June 2015:
Director | Number of 0.2 pence Ordinary Shares subject to the Award
|
|
Alan Hirzel | 16,937* |
|
Jim Warwick | 13,739 |
|
Jeff Iliffe | 6,543 |
|
* The award made to Alan Hirzel is in the form of conditional shares which will be delivered following vesting.
The Awards will vest on 26 October 2017.
For further information please contact:
Abcam | + 44 (0) 1223 696 000 |
Suzanne Smith, Company Secretary
| |
J.P.Morgan Cazenove - Nominated Adviser & Joint Corporate Broker | + 44 (0) 20 7742 4000 |
James Mitford / Alex Bruce - Nominated Adviser | |
Peel Hunt LLP - Joint Corporate Broker | + 44 (0) 20 7418 8900 |
Jock Maxwell MacDonald - Corporate Broking | |
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.
Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support and sells to over 100 countries. The Company was founded in 1998, and now employs over 820 people. Abcam was admitted to AIM in 2005 (AIM: ABC).
To find out more, please visit www.abcam.com
Related Shares:
ABC.L